Jim Cramer Recently Shed Light on These 13 Stocks

Page 4 of 12

9. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 69

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the stock has been going down, Cramer commented:

“Yes, it does. And let me tell you how I feel about this: I made a mistake here. I bought the stock, I bought it because they have a drug called COBENFY, which I think is going to be really good for severely mentally ill people. It has not worked. The president is very much, because he’s against these drug companies, it’s not been able to stabilize. I’m trying to figure out an action plan for my Charitable Trust. Have not been recommending the stock. I need an action plan. I don’t have it yet. You and I are in the same boat on this one.”

Bristol-Myers Squibb Company (NYSE:BMY) develops and markets biopharmaceuticals for cancer, cardiovascular, immunology, and neurological conditions. The company’s portfolio includes Eliquis, Opdivo, Revlimid, Camzyos, and several other therapies for serious and chronic diseases.

Page 4 of 12